Patent · US Active

Compounds for the treatment of Hepatitis C

US8129367B2 · kind B2 · utility

1Cited by
16References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 2008
Grant dateMar 6, 2012
Priority date
Expiry dateJul 19, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.